KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Receivables: 2009-2025

Historic Receivables for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $2.4 billion.

  • Bausch Health Companies' Receivables rose 15.43% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 billion, marking a year-over-year increase of 7.24%. This contributed to the annual value of $2.1 billion for FY2024, which is 7.11% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Receivables is $2.4 billion, which was up 9.37% from $2.2 billion recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Receivables ranged from a high of $2.4 billion in Q3 2025 and a low of $1.5 billion during Q1 2021.
  • Its 3-year average for Receivables is $2.0 billion, with a median of $2.1 billion in 2025.
  • Its Receivables has fluctuated over the past 5 years, first declined by 12.44% in 2021, then increased by 21.33% in 2024.
  • Over the past 5 years, Bausch Health Companies' Receivables (Quarterly) stood at $1.8 billion in 2021, then rose by 0.85% to $1.8 billion in 2022, then increased by 11.62% to $2.0 billion in 2023, then grew by 7.11% to $2.1 billion in 2024, then increased by 15.43% to $2.4 billion in 2025.
  • Its Receivables stands at $2.4 billion for Q3 2025, versus $2.2 billion for Q2 2025 and $2.1 billion for Q1 2025.